Paper17023272
PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal.
Hyoudou K and 5 others. Free Radic Biol Med, 2006. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Papers, record 17023272. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17023272
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catalase | Major topic |
| Lung Neoplasms | Major topic |
| Melanoma, Experimental | Major topic |
| Polyethylene Glycols | Major topic |
| Animals | |
| Blotting, Western | |
| Fireflies | |
| Hydrogen Peroxide | |
| Luciferases | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Oxidants | |
| Reactive Oxygen Species | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Survival Rate |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39447253 | Targeting catalase in cancer. | Redox Biol | 2024 | https://conductscience.org/library/papers/39447253 | PubMed |
| 38542138 | Antioxidant Enzymes in Cancer Cells: Their Role in Photodynamic Therapy Resistance and Potential as Targets for Improved Treatment Outcomes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542138 | PubMed |
| 37303173 | Reactive Oxygen Species and its Manipulation Strategies in Cancer Treatment. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/37303173 | PubMed |
| 35326089 | Redox-Related Proteins in Melanoma Progression. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35326089 | PubMed |
| 34777681 | Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34777681 | PubMed |
| 34595164 | Heme Oxygenase-1 at the Nexus of Endothelial Cell Fate Decision Under Oxidative Stress. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34595164 | PubMed |
| 28911429 | Comparison of free radical formation induced by baicalein and pentamethyl-hydroxychromane in human promyelocytic leukemia cells using electron spin resonance. | J Food Drug Anal | 2014 | https://conductscience.org/library/papers/28911429 | PubMed |
| 28647857 | ROS-modulated therapeutic approaches in cancer treatment. | J Cancer Res Clin Oncol | 2017 | https://conductscience.org/library/papers/28647857 | PubMed |
| 27775086 | Synergistic effect of sunlight induced photothermal conversion and H2O2 release based on hybridized tungsten oxide gel for cancer inhibition. | Sci Rep | 2016 | https://conductscience.org/library/papers/27775086 | PubMed |
| 27543846 | Hydrogen peroxide scavenger, catalase, alleviates ion transport dysfunction in murine colitis. | Clin Exp Pharmacol Physiol | 2016 | https://conductscience.org/library/papers/27543846 | PubMed |
| 27098859 | Columbianadin Inhibits Cell Proliferation by Inducing Apoptosis and Necroptosis in HCT116 Colon Cancer Cells. | Biomol Ther (Seoul) | 2016 | https://conductscience.org/library/papers/27098859 | PubMed |
| 24113073 | Effects of N-acetyl-L-cysteine on adhesive strength between breast cancer cell and extracellular matrix proteins after ionizing radiation. | Life Sci | 2013 | https://conductscience.org/library/papers/24113073 | PubMed |
| 23516420 | Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. | PLoS One | 2013 | https://conductscience.org/library/papers/23516420 | PubMed |
| 22395432 | Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue. | Cell Cycle | 2012 | https://conductscience.org/library/papers/22395432 | PubMed |
| 22117137 | Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. | Antioxid Redox Signal | 2012 | https://conductscience.org/library/papers/22117137 | PubMed |
| 21883043 | Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. | Antioxid Redox Signal | 2012 | https://conductscience.org/library/papers/21883043 | PubMed |
| 21778829 | Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21778829 | PubMed |
| 21734470 | Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". | Cell Cycle | 2011 | https://conductscience.org/library/papers/21734470 | PubMed |
| 21654190 | Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21654190 | PubMed |
| 21521946 | Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21521946 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17023272
GET https://conductscience.org/api/papers/v1/17023272/cited_by?page=2